Skip to content

The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period

The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000002958
Enrollment
Unknown
Registered
2020-02-02
Start date
2020-02-02
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Sponsors

1. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. patients diagnosed as Pneumonia caused by new coronavirus infection (2019-nCoV); 2. virus turned negative after treatment; 3. aged 18-70 years old; 4. patients with clear consciousness 5. Signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with serious illnesses, such as heart, liver, kidney, endocrine diseases and hematopoietic system disease; 2. Pregnant or lactating women; 3. Patients who have mental confusion, who with a history of drug abuse or dependence, who allergic to study medication, who have participated in another clinical trial within 3 months,or who have other conditions not suitable for clinical study.

Design outcomes

Primary

MeasureTime frame
St Georges respiratory questionnaire, SGRQ;pulmonary function;Incidence of adverse events;Modified Barthel Index, MBI;

Secondary

MeasureTime frame
6-minute walk test, 6MWT;

Countries

China

Contacts

Public ContactChanjuan Zheng

1. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine

chanjuanzheng@163.com+86 18971317115

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026